Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Sales (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Return on Sales for 5 consecutive years, with 85.23% as the latest value for Q4 2025.

  • For Q4 2025, Return on Sales fell 1931.0% year-over-year to 85.23%; the TTM value through Dec 2025 reached 85.23%, down 1931.0%, while the annual FY2023 figure was 14.55%, N/A changed from the prior year.
  • Return on Sales hit 85.23% in Q4 2025 for Kezar Life Sciences, down from 94.25% in the prior quarter.
  • Across five years, Return on Sales topped out at 129.73% in Q4 2022 and bottomed at 16.31% in Q4 2023.
  • Average Return on Sales over 5 years is 67.27%, with a median of 63.09% recorded in 2022.
  • Year-over-year, Return on Sales plummeted -14604bps in 2023 and then skyrocketed 12287bps in 2024.
  • Kezar Life Sciences' Return on Sales stood at 89.38% in 2021, then soared by 45bps to 129.73% in 2022, then plummeted by -113bps to 16.31% in 2023, then soared by 741bps to 104.54% in 2024, then dropped by -18bps to 85.23% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 85.23%, 94.25%, and 45.38% for Q4 2025, Q3 2025, and Q2 2025 respectively.